CGON (CG Oncology Therapeutics) Earnings per share growth rate in current year

Corporate emblem and logo of CG Oncology, Inc. (CGON)

CG Oncology, Inc. (CGON) has earned its status as an innovator in urological oncology by offering a lifeline for bladder cancer. The annual EPS growth trajectory confirms this success, with the current mark standing at -44.00. Strict patents and FDA approval serve as a moat for the business. Risks are mitigated through the diversification of mono- and combination therapy programs, which expand patient reach.

CG Oncology (CGON): Earnings growth in current year from 02/21/2024 to 11/18/2026

Analytical breakdowns and data insights for company CG Oncology Therapeutics (CGON)

- business market valuation indicators:
Basic company analysis:CG Oncology Corp
Manufactured products of CG Oncology Corp

The specific nature of CG Oncology, Inc. (CGON) as a biotech company in the clinical trial stage for bladder cancer therapy eliminates mass production costs, focusing financial results on operational efficiency and R&D. The annual EPS range dynamics reflect the percentage shift in net income per share, allowing investors to identify trend reversals and fundamental risks through indicator pivot points before they are priced into the quotes.

Direct competitors

Earnings per share growth rate in current year BeiGene Corp (ONC)|HALO (Halozyme Therapeutics, Inc.) - Earnings growth in current year|Earnings per share growth rate in current year revmed.com RVMD|Earnings growth in current year AAPG|Earnings growth in current year UroGen Pharma Ltd (URGN)|Earnings growth in current year BCAX (Bicara Corp)|Personalis Genomics (PSNL) - Earnings per share growth rate in current year|Erasca Oncology - Earnings growth in current year|DCTH: Earnings per share growth in current year|YMAB: Earnings growth in current year|Aura Bio (AURA) - Earnings growth in current year|CADL (Candel Therapeutics Inc.) - Earnings growth in current year|ARAY: Earnings per share increase in current year|Net earnings per share growth this year SLS (SELLAS Life Sciences Group, Inc.)|Net earnings per one share growth for the current year ACTU|Citius Oncology - Net earnings per share growth this year|Earnings per share increase in current year HURA|TARA: Net earnings per share growth this year|Earnings per share growth rate in current year Fate Pharma|Aadi Bioscience Inc (WHWK) - Earnings per share growth in current year|Earnings per share growth rate in current year TScan (TCRX)|Net earnings per share growth this year CSBR|xbiotech.com (XBIT) - Expected net earnings per share growth this year|Earnings per share growth in current year cel-sci.com (CVM)|OSTX - Earnings per share growth rate in current year|Radiopharm Theranostics - Net earnings per share growth this year|Earnings per share increase in current year ARTV|ANL - Earnings per share growth in current year|VERU - Earnings growth in current year|Tempest Therapeutics, Inc. (TPST) - Earnings per share growth in current year|XLO: Net earnings per one share growth for the current year|RENB (Renovaro Biosciences) - Earnings growth in current year|MURA: Earnings per share increase in current year|Net earnings per share growth this year KAPA (Kairos Pharma Ltd)|Net earnings per one share growth for the current year OKUR|CytoMed Therapeutics Limited - Net earnings per share growth this year|CRIS: Earnings per share growth this year|APLM - Earnings per share growth in current year|THAR - Earnings growth in current year|ADVB: Earnings growth in current year|Earnings per share growth this year GNPX|CLDI (Calidi Biotherapeutics, Inc.) - Earnings growth in current year|Earnings per share growth in current year SBFM|Earnings growth in current year XBIO|Net earnings per share growth this year Salarius Pharmaceuticals SLRX|Earnings growth in current year PPBT (Purple Biotech Ltd)|AONC - Net earnings per share growth this year|BGNE: Net earnings per share growth this year|Expected net earnings per share growth this year Checkpoint Therapeutics, Inc CKPT|ELEV: Earnings growth in current year|Earnings per share growth rate in current year iCAD Inc. (ICAD)|IKNA (Ikena) - Earnings growth in current year|Net earnings per share growth this year Notable Labs (NTBL)|Earnings growth in current year VIRX|Net earnings per share growth this year MorphoSys Corporation MOR|NAYA Biosciences - Net earnings per share growth this year|Net earnings per share change in current year Ascentage Pharma